Disease activity following fingolimod withdrawal in relapsing remitting multiple sclerosis: a monocentric Italian study

被引：0
|
作者：
Esposito, F. [1 ]
Ferre, L. [1 ]
Clarelli, F. [2 ]
Mogavero, A. [3 ]
Romeo, M. [4 ]
Colombo, B. [5 ]
Moiola, L. [6 ]
Martinelli, V. [5 ]
Leocani, L. [7 ]
Filippi, M. [5 ]
Comi, G. [4 ]
机构：
[1] Ist Sci San Raffaele, Lab Human Genet Neurol Disorders, Neurol & Neurorehabil, Milan, Italy
[2] Ist Sci San Raffaele, Lab Human Genet Neurol Disorders, Milan, Italy
[3] Univ Vita Salute San Raffaele, Neurol, Milan, Italy
[4] Ist Sci San Raffaele, Neurol & Neurorehabil, Milan, Italy
[5] Univ Vita Salute San Raffaele, San Raffaele Sci Inst, Dept Neurol, Milan, Italy
[6] Univ Vita Salute, Sci Inst H San Raffaele, Dept Neurol, Milan, Italy
[7] Ist Sci San Raffaele, Neurorehabil, Milan, Italy
来源：
EUROPEAN JOURNAL OF NEUROLOGY | 2019年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
EPR1088
引用
收藏
页码：166 / 166
页数：1
相关论文
共 50 条
  • [1] Comparative effectiveness of dimethylfumarate and fingolimod in an Italian monocentric cohort of relapsing remitting multiple sclerosis patients
    Moiola, L.
    Esposito, F.
    Di Cristinzi, M.
    Ferre, L.
    Signori, A.
    Sferruzza, G.
    Radaelli, M.
    Sangalli, F.
    Dalla Costa, G.
    Colombo, B.
    Boneschi, F. Martinelli
    Rocca, M. A.
    Martinelli, V.
    Filippi, M.
    Sormani, M. P.
    Comi, G.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2019, 26 : 677 - 677
  • [2] Comparative effectiveness of dimethylfumarate and fingolimod in an Italian monocentric cohort of relapsing remitting multiple sclerosis patients.
    Moiola, L.
    Esposito, F.
    Di Cristinzi, M.
    Ferre', L.
    Sferruzza, G.
    Romeo, M.
    Radaelli, M.
    Sangalli, F.
    Robotti, M.
    Dallacosta, G.
    Colombo, B.
    Boneschi, F. Martinelli
    Rocca, M. A.
    Signori, A.
    Martinelli, V.
    Filippi, M.
    Sormani, M.
    Comi, G.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 86 - 87
  • [3] Fingolimod for relapsing-remitting multiple sclerosis
    La Mantia, Loredana
    Tramacere, Irene
    Firwana, Belal
    Pacchetti, Ilaria
    Palumbo, Roberto
    Filippini, Graziella
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2016, (04):
  • [4] Glioblastoma following treatment with fingolimod for relapsing-remitting multiple sclerosis
    Sharim, Justin
    Tashjian, Randy
    Golzy, Nima
    Pouratian, Nader
    [J]. JOURNAL OF CLINICAL NEUROSCIENCE, 2016, 30 : 166 - 168
  • [5] Rituximab following natalizumab withdrawal in relapsing remitting multiple sclerosis
    Beaber, B. E.
    Mallari, G.
    Le, D.
    Langer-Gould, A. M.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2014, 20 : 193 - 193
  • [6] Withdrawal of fingolimod treatment for relapsing-remitting multiple sclerosis: report of six cases
    Hakiki, Bahia
    Portaccio, Emilio
    Giannini, Marta
    Razzolini, Lorenzo
    Pasto, Luisa
    Amato, Maria Pia
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2012, 18 (11) : 1636 - 1639
  • [7] Regional efficacy of fingolimod in relapsing remitting multiple sclerosis
    Bogdan, I.
    Warren, C.
    Koniotes, A.
    Ruffer, G.
    Newell, B.
    Fisniku, L.
    Bremner, S.
    Gabel, M. C.
    Rashid, W.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2017, 24 : 192 - 192
  • [8] Fingolimod hydrochloride for the treatment of relapsing remitting multiple sclerosis
    Thomas, Katja
    Proschmann, Undine
    Ziemssen, Tjalf
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2017, 18 (15) : 1649 - 1660
  • [9] Oral fingolimod for relapsing-remitting multiple sclerosis
    Doggrell, Sheila A.
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2010, 11 (10) : 1777 - 1781
  • [10] Fingolimod in a monocentric cohort of 123 patients with relapsing-remitting multiple sclerosis: impact on relapses and disability
    Maillart, E.
    Roux, T.
    Du Montcel, S. Tezenas
    Lubetzki, C.
    Papeix, C.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2015, 21 : 754 - 755
12345